ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "biomarkers and spondylarthropathy"

  • Abstract Number: 580 • 2012 ACR/ARHP Annual Meeting

    Changes in Sclerostin, Dickkopf-1 and Serum Markers of Inflammation, Cartilage and Bone Turnover in Patients with Axial Spondyloarthritis Treated with Adalimumab

    Susanne Juhl Pedersen1, Inge Juul Sørensen2, Julia S. Johansen3, Patrick Garnero4, Anne Gitte Loft5, Jens Skoedt6, Gorm Thamsborg7, Karsten Asmussen8, Elka Kluger9, Jesper Nørregaard10, Torben Grube Christensen11 and Mikkel Østergaard12, 1Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, 2Department of Rheumatology, Hvidovre Hospital, Copenhagen, Denmark, 3Department of Internal Medicine and Oncology, Herlev Hospital, Herlev, Denmark, 4INSERM, UMR 1033, Lyon and Cisbio Bioassays, Bagnols/Cèze, France, 5Department of Rheumatology, Sygehus Lillebaelt, Vejle, Denmark, 6Department of Rheumatology, Gentofte Hospital, Copenhagen, Denmark, 7Dep. of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 8Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, 9King Christian 10th Rheumatism Hospital at Gråsten, Graasten, Denmark, 10Dep of Rheumatology, Hørsholm Hospital, Hørsholm, Denmark, 11Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark, 12Copenhagen University Hospital Glostrup, Copenhagen, Denmark

    Background/Purpose: Few studies have investigated changes in plasma sclerostin and Dickkopf1 (DKK-1) in relation to other biomarkers of inflammation, cartilage and bone turnover during treatment…
  • Abstract Number: 2496 • 2012 ACR/ARHP Annual Meeting

    Elevated Serum Level of the Vascular Endothelial Growth Factor Is Highly Predictive for New Syndesmophytes Formation in Patients with Ankylosing Spondylitis

    Denis Poddubnyy1, Kristina Conrad2, Uta Syrbe2, Hildrun Haibel3, Heiner Appel2, Martin Rudwaleit4 and Joachim Sieper5, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Charité Medical University, Campus Benjamin Franklin, Berlin, Germany, 3Medical Department I, Rheumatology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany, 4Endokrinologikum Berlin, Berlin, Germany, 5Medical Department I, Rheumatology, Charité Universitätesmedizin Berlin, Berlin, Germany

    Background/Purpose: In the recent years several predictors of radiographic spinal progression/syndesmophyte formation in ankylosing spondylitis (AS) were identified: syndesmophytes at baseline (the strongest predictor so…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences